TScan Therapeutics Announces Upcoming Poster Presentations at the 37th Society for Immunotherapy of Cancer Annual Meeting
WALTHAM, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…
WALTHAM, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…
COPENHAGEN, Denmark, Oct. 05, 2022 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or…
WOBURN, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the…
MIAMI, Oct. 05, 2022 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…
LEXINGTON, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) — Agenus (NASDAQ: AGEN), an immuno-oncology company with…
Licensed exclusive worldwide rights from Emory University to patents and patent applications for certain methods…
FREMONT, CA, Oct. 05, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ:…
MIAMI, Oct. 05, 2022 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Common Stock: Nasdaq: FBIO) (Preferred…
– Seven abstracts accepted, including one oral presentation highlighting long-term data demonstrating Bylvay® (odevixibat) durable…
Poster to provide details on study design and expansion phase for ongoing Phase 1 study…
BELTSVILLE, Md., Oct. 05, 2022 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company…
TNG260 is in preclinical development as a first-in-class CoREST deacetylase inhibitor for the treatment of…
Oral Presentation of C-144-01 Trial Cohorts 2 and 4 SAN CARLOS, Calif., Oct. 05, 2022…
TORONTO and HOUSTON, Oct. 05, 2022 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA…
ZUG, Switzerland and BOSTON, Oct. 05, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a…
Five poster presentations to include preclinical data describing new T-cell reprogramming technology being incorporated in…
BOSTON, Oct. 05, 2022 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted…
MILAN, Italy and NEW YORK, Oct. 05, 2022 (GLOBE NEWSWIRE) — Genenta Science (NASDAQ: GNTA),…
BOSTON, Oct. 05, 2022 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company…
NEW YORK, Oct. 05, 2022 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…